The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Administration Of Thrombopoietin Agonist Compounds - EP3127427

The patent EP3127427 was granted to Novartis on Jan 8, 2020. The application was filed on May 27, 2010 under application number EP16183711A. The patent is currently recorded with a legal status of "Revoked".

EP3127427

NOVARTIS
Application Number
EP16183711A
Filing Date
May 27, 2010
Status
Revoked
Aug 27, 2021
Publication Date
Jan 8, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TEVA PHARMACEUTICALSOct 8, 2020D YOUNGADMISSIBLE
ZENTIVA KSOct 8, 2020DENTONS UK AND MIDDLE EASTADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5766581
DESCRIPTIONWO0189457
DESCRIPTIONWO03098992
DESCRIPTIONWO2008136843
OPPOSITIONWO0189457
OPPOSITIONWO2008136843
OPPOSITIONWO2010045310
OPPOSITIONWO2010129738
OPPOSITIONWO2010138656
SEARCHWO2008136843

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents